Generic Dry Powder Inhaler

Drug identity has not yet been verified against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)NCT04816604Gossamer Bio USA, Inc.Phase 2Terminated2026-09-09Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.